/
AEON
$0.27-$0.00 (-1.60%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$13.4M
49M shares
52-week range
$0.22 – $1.45
4% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
XASE
CS
Change$-662.13
AEON Biopharma, Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
www.aeonbiopharma.com- Employees
- 8
- IPO / List date
- Jul 24, 2023
- HQ
- ALISO VIEJO, CA
Held by traders on TradeandTell
No one on the platform currently holds AEON.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AEON as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-02-26 | 1-for-72reverse |
Recent trades on TradeandTell
No one on the platform has traded AEON yet.
